SB 31

Summary

SB 31, the An Act Increasing The Bond Authorization For The Connecticut Bioscience Innovation Fund, was introduced in the Senate on Feb 4, 2026 by Sen. Tony Hwang (R). It was referred to Finance, Revenue and Bonding, and last saw action on Mar 18, 2026: Change of Reference, House to Committee on Finance, Revenue and Bonding.

Record

Text

SB 31 has 1 roll call.

General Assembly  Proposed Bill No. 31
      February Session, 2026  LCO No. 144
    Referred to Committee on COMMERCE
    Introduced by:
     SEN. HWANG, 28th Dist.
 AN ACT INCREASING THE BOND AUTHORIZATION FOR THE
 CONNECTICUT BIOSCIENCE INNOVATION FUND.
 Be it enacted by the Senate and House of Representatives in General
 Assembly convened:
1  That section 32-41dd of the general statutes be amended to increase
2      the bond authorization for the Connecticut Bioscience Innovation Fund
3      by twenty-five million dollars.
       Statement of Purpose:
       To increase funding for bioscience innovation.
    LCO No. 144  1 of 1

To increase funding for bioscience innovation.

Sponsors

Sen. Tony Hwang (R) sponsors SB 31 alone.

Tony Hwang

Sen. · R–28 · Sponsor

Show 1 of 1 row

PreviousNext

Committees

SB 31 went before 2 committees: Commerce and Finance, Revenue and Bonding.

Commerce

Commerce

Referred to · Feb 4, 2026

Finance, Revenue and Bonding

Finance, Revenue and Bonding

Referred to · Feb 11, 2026

History

SB 31 has taken 4 actions since Feb 4, 2026, the latest on Mar 18, 2026.

Votes

SB 31 went to 1 roll call in the J, the latest on Feb 10, 2026 at 0–0.

Source: cga.ct.gov · legiscan.com